Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Wen-Tien Chen"'
Autor:
Huan Dong, Shaun Tulley, Qiang Zhao, Leong Cho, Donghai Chen, Michael L. Pearl, Wen‐Tien Chen
Publikováno v:
Cancer Medicine, Vol 8, Iss 8, Pp 3864-3874 (2019)
Abstract Circulating tumor cells (CTCs) are important clinical indicators of metastatic progression and treatment efficacy. However, because of their low number and heterogeneity, reliable patient‐derived CTC models are not readily available. We re
Externí odkaz:
https://doaj.org/article/f801d1f138a34f379a934870f463d9b0
Autor:
Yue Zhang, Kevin Zarrabi, Wei Hou, Stefan Madajewicz, Minsig Choi, Stanley Zucker, Wen-Tien Chen
Publikováno v:
Biomedicines, Vol 6, Iss 2, p 69 (2018)
Colorectal carcinoma (CRC) is the second leading cause of cancer-related mortality. The goals of this study are to evaluate the association between levels of invasive circulating tumor cells (iCTCs) with CRC outcomes and to explore the molecular char
Externí odkaz:
https://doaj.org/article/2143da1d472041f1b3245ba8e6f2cbc2
Autor:
Wen-Tien Chen, 陳文田
95
In order to raise the operational efficiency, modern enterprises often integrate PLM information to assist handling large amount of intelligence property produced in the product development process. However, many enterprises only regard PLM s
In order to raise the operational efficiency, modern enterprises often integrate PLM information to assist handling large amount of intelligence property produced in the product development process. However, many enterprises only regard PLM s
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/24096105360854746118
Publikováno v:
Gynecologic Oncology. 147:426-432
Management of epithelial ovarian cancer (EOC) could use serial measurements of invasive circulating tumor cells (iCTCs) for monitoring therapeutic response and early detection of disease progression/recurrence. Goals of this study are to develop an i
Autor:
Wen-Tien Chen, Michael L. Pearl, Donghai Chen, Qiang Zhao, Shaun Tulley, Huan Dong, Leong Cho
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 8, Pp 3864-3874 (2019)
Cancer Medicine, Vol 8, Iss 8, Pp 3864-3874 (2019)
Circulating tumor cells (CTCs) are important clinical indicators of metastatic progression and treatment efficacy. However, because of their low number and heterogeneity, reliable patient‐derived CTC models are not readily available. We report here
Autor:
Michael L. Pearl, Huan Dong, Shaun Tulley, Qiang Zhao, Wen-Tien Chen, Qiao Zhang, Marc G. Golightly, Stanley Zucker, Jie Yang
Publikováno v:
Gynecologic Oncology. 134:581-590
Goals Circulating tumor cells (CTCs) have been introduced as a biomarker in detecting advanced epithelial ovarian cancer (EOC). The goals are to examine the prevalence of the invasive subpopulation of CTCs (iCTCs) in patients at high risk of EOC and
Autor:
Charles J. Ryan, Elizabeth Gilbert, Terence W. Friedlander, Pamela L. Paris, Vivian Weinberg, Qiang Zhao, Huan Dong, Shaun Doty, Vy Ngo, Gayatri Premasekharan, Wen Tien Chen
Publikováno v:
International Journal of Cancer. 134:2284-2293
The Vitatex cell-adhesion matrix (CAM) platform allows for isolation of invasive circulating tumor cells (iCTCs). Here we sought to determine the utility of prostate-specific membrane antigen (PSMA) as a metastatic castration-resistant prostate cance
Autor:
Benjamin A. Gartrell, Alexander G Vandell, Gerald H. Sokol, Mack Roach, Wen-Tien Chen, G. Del Priore, Avi S. Retter, Howard I. Scher
Publikováno v:
Annals of Oncology. 30:v342
Background Androgen deprivation therapy (ADT) is standard treatment for rising PSA with/without circulating tumor cells (CTCs) but adverse events (AEs) limit patient acceptance. We report results of SM-88 (D,L-alpha-metyrosine; racemetyrosine [USAN])
Autor:
Wen-Tien Chen, Gerald H. Sokol, Alexander G Vandell, Mack Roach, Benjamin A. Gartrell, Avi S. Retter, Giuseppe Del Priore
Publikováno v:
Journal of Clinical Oncology. 37:83-83
83 Background: Absolute PSA change is an imperfect surrogate of clinical benefit; CTCs and PSA doubling time (DT) may also be used as a surrogate of progression (PD). Hormone therapy (HT) often leads to a rapid decline in PSA, however non-HT may be e
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1406
The ability to capture, enrich, and propagate circulating cancer cells/circulating tumor cells (CTCs) for downstream analyses such as ex vivo drug-sensitivity testing of short-term cultures of CTCs, single cell sorting of CTCs by fluorescence activat